Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Core Insights - Heartflow, Inc. is participating in a fireside chat at the Morgan Stanley Technology, Media & Telecom Conference on March 3, 2026, showcasing its leadership in AI technology for coronary artery disease [1] Company Overview - Heartflow is transforming coronary artery disease management, which is the leading cause of death globally, into a condition that can be detected early and managed effectively [4] - The Heartflow One platform utilizes AI to convert coronary CTA images into personalized 3D heart models, providing actionable insights into plaque characteristics and blood flow without invasive procedures [4] Technology and Research - Heartflow's technology is supported by the world's largest coronary imaging dataset, with over 160 million annotated CTA images, enabling advanced AI models that deliver accurate insights across diverse patient populations [5] - The company's AI-driven solutions have been validated through over 200 studies involving more than 365,000 patients, achieving coronary CTA image acceptance rates exceeding 97% [5] - Heartflow's solutions are backed by ACC/AHA guidelines and over 600 peer-reviewed publications, having redefined care management for over 500,000 patients worldwide [3][5] Commercial Presence - Heartflow has been adopted by more than 1,400 institutions globally, indicating a strong commercial presence and commitment to making its technology widely available [3] - The company ensures seamless clinical integration with upgraded workflows, providing quality-reviewed analyses instantly upon order, facilitating timely decision-making for clinicians [5]